Related Funds
Fund Name | Location |
A. M. Pappas & Associates | Durham, North Carolina, United States |
BW Offshore | Norway, Oslo |
Caffeinated Capital | California, San Francisco, United States |
Crystal-Optech | China, Hangzhou, Zhejiang |
Harmony Medical | - |
HumanCo | New York, New York, United States |
Karel Electronics | Ankara, Ankara, Turkey |
Leo Partners Investment | Seoul, Seoul-t'ukpyolsi, South Korea |
NorthPort Investments | Minnesota, Northfield, United States |
Ofir Technologies | - |
Old Ironsides Energy | Boston, Massachusetts, United States |
Ookbee | Bangkok, Krung Thep, Thailand |
Quester | England, London, United Kingdom |
Reliance Modal Ventura | - |
Scala Ventures | Lugano, Switzerland, Ticino |
Securian Ventures | Minnesota, Saint Paul, United States |
Social Impact Fund | - |
Sunnybrook Research Institute | - |
Tomita Pharmaceutical | Japan, Kumamoto, Kumamoto Prefecture |
Treasure Valley Angel Fund | - |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
Zhengxi Biotechnology | 07 Oct 2023 | Zhangjiang, Hunan, China | |||
Enrikenuo | 14 Jul 2023 | Nanjing, Jiangsu, China | |||
Proswell | $15M | 01 Mar 2022 | Beijing, Beijing, China | ||
$463K | 28 Aug 2017 | China, Zhejiang | |||
Reload | $1M | 27 Jun 2017 | China, Changning District | ||
UCHOICE | $1M | 10 May 2017 | China, Zhejiang | ||
GEEWISE | $3M | 14 Apr 2017 | China, Beijing | ||
AB Pharma | $1M | 25 Jan 2016 | Minhang District, China | ||
Reload | $2M | 23 Dec 2015 | China, Changning District |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
Zhengxi Biotechnology | 07 Oct 2023 | Zhangjiang, Hunan, China | |||
Enrikenuo | 14 Jul 2023 | Nanjing, Jiangsu, China | |||
Proswell | $15M | 01 Mar 2022 | Beijing, Beijing, China | ||
$463K | 28 Aug 2017 | China, Zhejiang | |||
Reload | $1M | 27 Jun 2017 | China, Changning District | ||
UCHOICE | $1M | 10 May 2017 | China, Zhejiang | ||
GEEWISE | $3M | 14 Apr 2017 | China, Beijing | ||
AB Pharma | $1M | 25 Jan 2016 | Minhang District, China | ||
Reload | $2M | 23 Dec 2015 | China, Changning District |